Cargando…
Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review
Atrial fibrillation globally affects roughly 33.5 million people, making it the most common heart rhythm disorder. It is a crucial arrhythmia, as it is linked with a variety of negative outcomes such as strokes, heart failure and cardiovascular mortality. Atrial fibrillation can reduce quality of li...
Autores principales: | Alrumayh, Abdullah, Alobaida, Muath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018546/ https://www.ncbi.nlm.nih.gov/pubmed/33783271 http://dx.doi.org/10.1080/07853890.2021.1905873 |
Ejemplares similares
-
Rate control strategies for atrial fibrillation
por: Alobaida, Muath, et al.
Publicado: (2021) -
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
por: Pope, Marita Knudsen, et al.
Publicado: (2021) -
Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2020) -
Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022) -
A Retrospective Cohort Study on Predictors for Rehospitalizations With Recurrence of Atrial Fibrillation Post-Catheter Ablation for Atrial Fibrillation
por: Shah, Farhan A, et al.
Publicado: (2021)